SCHEDULE: Affinity Funds Disclose 7.17% Stake in NextCure
Beneficial Ownership Disclosure
Affinity Healthcare Fund, LP and Affinity Asset Advisors, LLC have disclosed a 7.17% beneficial ownership stake in NextCure, Inc., totaling 191,882 common shares.
Summary
- Affinity Healthcare Fund, LP and Affinity Asset Advisors, LLC reported beneficial ownership of 191,882 shares of NextCure, Inc. common stock.
- This ownership represents 7.17% of NextCure, Inc.'s outstanding common stock.
- The percentage is calculated based on 2,676,110 shares of common stock outstanding as of August 4, 2025, as reported in NextCure's Quarterly Report on Form 10-Q filed on August 7, 2025.
- Both Affinity Healthcare Fund, LP and Affinity Asset Advisors, LLC possess shared voting power and shared dispositive power over all 191,882 shares.
- The reporting persons certified that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of NextCure, Inc.
Sentiment
Score: 5
Explanation: This is a factual disclosure of beneficial ownership, which is neutral in sentiment. While a significant institutional stake can be viewed favorably by some investors, the filing itself does not contain any forward-looking statements or performance metrics to indicate a strong positive or negative sentiment.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional investor holding 7.17% of outstanding shares, which may influence market perception of the company's institutional backing.
Key Dates
| Date | Description |
|---|---|
| 2025-08-04 | Date as of which 2,676,110 shares of Common Stock were outstanding, as reported in NextCure's Form 10-Q. |
| 2025-08-07 | Date NextCure, Inc. filed its Quarterly Report on Form 10-Q with the SEC. |
| 2025-09-30 | Date of event requiring the filing of this statement. |
| 2025-11-14 | Date of filing of this Schedule 13G Amendment No. 2. |
Keywords
NextCure, Affinity Healthcare Fund, Affinity Asset Advisors, Schedule 13G, beneficial ownership, common stock, institutional investment, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.